Sensitive miRNA markers for the detection and management of NSTEMI acute myocardial infarction patients

Abstract

miRNA is a potentially sensitive biomarker for NSTEMI AMI patients for disease detection and treatment monitoring. The sensitivities were comparable to cTnT for diagnostic accuracy and patients with sustained or higher levels were correlated to secondary complications.